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ABSTRACT
The DNA damage response (DDR) is an extensive
signaling network that is robustly mobilized by DNA
double-strand breaks (DSBs). The primary trans-
ducer of the DSB response is the protein kinase,
ataxia-telangiectasia, mutated (ATM). Here, we es-
tablish nuclear poly(A)-binding protein 1 (PABPN1)
as a novel target of ATM and a crucial player in the
DSB response. PABPN1 usually functions in regula-
tion of RNA processing and stability. We establish
that PABPN1 is recruited to the DDR as a critical reg-
ulator of DSB repair. A portion of PABPN1 relocal-
izes to DSB sites and is phosphorylated on Ser95 in
an ATM-dependent manner. PABPN1 depletion sen-
sitizes cells to DSB-inducing agents and prolongs
the DSB-induced G2/M cell-cycle arrest, and DSB
repair is hampered by PABPN1 depletion or elim-
ination of its phosphorylation site. PABPN1 is re-
quired for optimal DSB repair via both nonhomol-
ogous end-joining (NHEJ) and homologous recom-
bination repair (HRR), and specifically is essential
for efficient DNA-end resection, an initial, key step
in HRR. Using mass spectrometry analysis, we cap-
ture DNA damage-induced interactions of phospho-
PABPN1, including well-established DDR players as
well as other RNA metabolizing proteins. Our results
uncover a novel ATM-dependent axis in the rapidly
growing interface between RNA metabolism and the
DDR.
INTRODUCTION
The double-strand break (DSB) is a severe DNA lesion
when generated by internal or external DNA damaging
agents. Failure to repair DSBs has major consequences
for genome integrity and cell fate, and may result in un-
due cell death or genomic rearrangements that may lead to
cancer formation (1,2). DSBs vigorously trigger the DNA
damage response (DDR), an elaborate signaling network
that reaches out to all cellular compartments and mobi-
lizes numerous cellular processes (3–5). This network is
based on a core of dedicated DDR players and vast, tem-
porary recruitment of additional proteins from other phys-
iological circuits. DSB repair is conducted by a highly co-
ordinated spatiotemporal cascade that begins with mas-
sive recruitment of DSB ‘sensors’ to DNA breaks (6),
and subsequent transmission of a signal to protein kinases
that act as transducers that relay the signal to numerous
downstream effectors. Two major DSB repair pathways are
utilized: end-resection-independent, canonical nonhomol-
ogous end-joining (C-NHEJ) and resection-dependent ho-
mologous recombination repair (HRR) (5,7). Additional,
minor resection-dependent pathways are single-strand an-
nealing (SSA) and alternative end-joining (Alt-EJ) reviewed
in (7,8). Of these pathways, only HRR is error-free. In
higher eukaryotes, the predominant DSB repair pathway
throughout the cell cycle is C-NHEJ, which rejoins broken
ends after their processing (9). The HRR pathway, which is
active only in the late S and G2 phases of the cell cycle, is
based on homologous recombination using the intact sister
chromatid as a template to accurately retrieve the missing
information in the broken copy, making it error-free (8,10).
A delicate balance exists between the different repair path-
ways, which is influenced by cell type, cell cycle stage and
the structure and amount of DSBs. Interference with this
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balance may abrogate DSB sealing or increase the extent of
error-prone repair, elevating genomic aberrations (11–13).
The assembly of the cellular response to DSB is based
on a wide range of protein posttranslational modifications
(PTMs) (14–16). The predominant damage-induced PTMs
are poly(ADP-ribosylation), phosphorylation and modifi-
cation by the ubiquitin family proteins. Phosphorylation
typically marks many proteins that are recruited to DNA
damage sites as well as core histones in the vicinity of DNA
breaks. The chief transducer of this massive response is the
serine–threonine protein kinase, ataxia-telangiectasia mu-
tated (ATM), which is activated following DSB induction
and in turn phosphorylates a plethora of effectors in vari-
ous DDR pathways (17–19). ATM is a homeostatic protein
kinase with functions in many cellular circuits (18,20). It is
a member of the PI3 kinase-related protein kinase (PIKK)
family, which includes, among others, the catalytic sub-
unit of the DNA-dependent protein kinase (DNA-PKcs)
(21,22) and the A-T and RAD3-related protein (ATR) (23).
The three protein kinases maintain a complex functional
crosstalk in response to various genotoxic stresses (19,24–
26). Key ATM effectors modulate biological pathways that
affect numerous physiological circuits. Thus, the investiga-
tion of new branches of this network often leads to different
aspects of cellular physiology.
The wealth of potential DDR players borrowed from the
RNA metabolism, which were detected in many screens for
new DDR players (27–31), points at a growing, broad in-
terface between the DDR and the RNA arenas. Indeed,
besides global approaches, work focusing on specific RNA
binding proteins (RBPs) has highlighted their roles in the
DDR (32–38). They regulate the levels of DDR proteins at
various post-transcriptional levels, regulate R-loop forma-
tion and formation of hazardous DNA topology at damage
sites, and play direct roles in DNA repair. Yet our knowl-
edge of this increasingly appreciated link between the DDR
and RNA metabolism is limited, especially when it comes
to focused studies on individual players and understand-
ing their functional significance and the relevant mecha-
nisms. We came across a novel player in this intriguing co-
alesce when nuclear poly(A)-binding protein 1 (PABPN1)
was identified as potential ATM substrate in a phospho-
proteomic screen carried out in our laboratory in order to
explore theDSB-induced dynamics of the nuclear phospho-
proteome (31).
PABPN1 plays an important role in various aspects of
RNA processing and stability (39): it binds poly(A) tails
of pre-mRNAs while stimulating polyadenylation (40–42),
and was recently shown to be a suppressor of alterna-
tive cleavage and polyadenylation (APA) (43,44). APA is
a widespread post-transcriptional phenomenon that con-
tributes to the complexity of the transcriptome by gener-
ating isoforms that differ either in their coding sequence or
in their 3′ untranslated regions (UTRs) (45). Here, we show
that PABPN1 is an ATM substrate, which plays a role in
regulating DSB repair. Proteomic analysis suggests that in
response to DNA damage PABPN1 interacts with several
known and new DDR players including other regulators of
mRNA metabolism.
MATERIALS AND METHODS
Chemical reagents, antibodies and immunoblotting
DharmaFECT1 transfection reagent was obtained from
Dharmacon (GE Dharmacon, Lafayette, CO, USA). Neo-
carzinostatin (NCS) was obtained from Sigma–Aldrich (St.
Louis, MO, USA). The ATM inhibitor, KU55933 (46), the
DNA-PK inhibitor, NU7441 (47) and the ATR inhibitor,
AZ20 (48) were obtained from Tcris Bioscience (Bristol,
UK). Anti-53BP1 mouse monoclonal antibody was a gen-
erous gift from T. Halazonetis, anti-53BP1 polyclonal anti-
body was obtained fromNovus Biologicals, LLC (Littleton
CO, USA), anti-pS139-H2AX monoclonal antibody was
obtained from Merck Millipore (Darmstadt, Germany),
anti-PABPN1 and anti-BRCA1 antibodies were obtained
from Abcam (Cambridge, MA, USA), phospho-antibodies
against phosphorylated Ser 95 of PABPN1 and phospho-
rylated KAP-1 were obtained from Bethyl Laboratories,
Inc. (Montgomery, TX, USA), anti-ATM obtained from
Sigma–Aldrich (St. Louis, MO, USA), anti-HSC70 mon-
oclonal antibody was obtained from Santa Cruz Biotech-
nology Inc. (Santa Cruz, CA, USA), anti-RAD51 was ob-
tained from Chalbiochem, Inc. (San Diego, CA, USA), an-
timouse and anti-rabbit IgG, Alexa 488/568/633 were pur-
chased from Molecular Probes (Leiden, Netherlands), and
HRP-conjugated anti-rabbit IgG and anti-mouse IgG were
obtained from Jackson Immunoresearch Laboratories, Inc.
(West Grove, PA, USA). Immunoblotting was carried out
as previously described (49).
Cell lines
HeLa andU2-OS cells were grown inDMEMmediumwith
10% fetal bovine serum at 37◦C in 5% CO2 atmosphere.
Vectors and constructs
PABPN1 cDNA cloned in pCMV-AC-GFP and PABPN1
cDNA resistant to siRNA2––WT or mutated in serine95
(S95A, S95D)––cloned in pcDNA5/FRT/V5-His TOPO
vector, were a kind gift fromR.Agami (Netherlands Cancer
Institute, Amsterdam, The Netherlands). PABPN1 cDNA
resistant to siRNA2––WT or mutated on serine95 (S95A,
S95D)––was cloned in pEGFP-C1 vector.
RNA interference
siRNAs were obtained from Dharmacon. Two cus-
tom designed siRNAs were used to target PABPN1
(siRNA1: UUAGAUGAGUCCCUAUUUA, siRNA2:
AGUCAACCGUGUUACCAUAUU). siRNA targeting
ATM (GACUUUGGCUGUCAACUUUCG), irrelevant
siRNAs targeting Luciferase (CGUACGCGGAAUACU-
UCGA) or GFP (GGAGCGCACCATCTTCTTC) carry
the OnTarget Plus modifications. Cells were grown to 50%
confluence and transfected with siRNA using Dharma-
FECT1 transfection reagent according to manufacturer’s
instructions.
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Immunoprecipitation
U2-OS cells were harvested and lysed in RIPA lysis buffer
or in 0.5% NP40 for CO-IP. 0.5–1 mg protein extract was
incubated with an antibody against PABPN1 or with IgG
(control) and incubated overnight, rotating, at 4◦C. The rest
of the extract was collected and kept as an input. Protein-
A sepharose beads were washed four times and centrifuged
between each time (5000 RPM, 2 min, 4◦C) and incu-
bated with the immune complexes for 1 h while rotating
at 4◦C. Immune complexes were pulled-down (5000 RPM,
2 min, 4◦C). Supernatants were collected and the pellets
were washed four times and alternately centrifuged (5000
RPM, 2 min, 4◦C). Total cell extract, immune complexes,
and supernatants were boiled in sample buffer, loaded on
8–10% SDS-PAGE and transferred onto a nitrocellulose
membrane.
Colony forming assay
Hela cells double-transfected with siRNA against ATM,
PABPN1 and non-targeted control siRNA were plated in
triplicates at densities of 100–5000 cells per 60 mm plate.
Seventy two hours after transfection, cells were treated with
various doses of NCS (5, 7.5, 10, 12.5 ng/ml) or IR (2, 4, 8,
12Gy). Cells were grown for 10–14 days and then were fixed
and stained with 2% crystal violet in 50% ethanol. Colonies
were counted using a dissection microscope.
Cell-cycle analysis
U2-OS cells were transfected with siRNA against ATM,
PABPN1 and Luciferase. Seventy two hours after transfec-
tion, cells were treated with 3–4 ng/ml NCS and harvested
at various time points. Cell-cycle checkpoint analysis was
carried out using a BD ACCURI C6 flow cytometer (Ann
Arbor, MI, USA) after DNA staining with propidium io-
dine. Statistical analysis of results was carried out using the
FlowJo software (Ashland, OR, USA).
Laser-induced localized DSBs
U2-OS cells were grown on glass-bottomed 35 mm dishes
(Matek Corp., Ashland, MA, USA) and transfected with
GFP-tagged PABPN1 using Fugene6 (Roche). Twenty four
hours later cells were irradiated with a focused 800 nm
laser beam in a Zeiss LSM 510 Meta confocal micro-
scope equipped with a Spectra-Physics Mai-Tai multipho-
ton laser; GFP-tagged PABPN1 was monitored.
Immunofluorescence
U2-OS cells were plated on 22 mm glass coverslips, treated
with 3.5 ng/ml NCS or 1 Gy of IR, fixed in 4% buffered
paraformaldehyde for 15 min, and permeabilized in PBS
containing 0.5% Triton X-100. Coverslips were blocked for
15 min with 10% bovine serum albumin in PBS, incubated
after NCS treatments for 1.5 h at room temperature with
primary antibodies diluted in primary antibody dilution
buffer (Biomeda Corp., Foster City, CA,USA), and washed
and incubated with secondary antibody for 30 min. Cell nu-
clei were stained with DAPI. The coverslips were washed
three times with PBS after each step. The procedure was
performed at room temperature. Nuclear foci were quan-
tified using the ImageJ software (http://imagej.nih.gov/ij/).
200–300 cells were counted per time point.
DSB repair pathway assays
U2-OS cells bearing a single copy integration of the re-
porters DR-GFP (Gene conversion (50), EJ2 (AltNHEJ)
and EJ5 (NHEJ) (51) or SSR (NHEJ/Recombination bal-
ance (52)) were used to analyze the different DSB repair
pathways. In all cases, cells were plated in 10 cm dishes. One
day after seeding, they were infected with a lentivirus har-
boring an I-SceI and labeled with BFP (53) using a multi-
plicity of infection (M.O.I) of 5. Six hours after infection the
same volume of fresh medium was added. Cells were grown
for 48 h, fixed with 4% paraformaldehyde, and washed with
PBS prior to visualization with a fluorescent microscope
for blue, green and, in the case of the SSR, red fluores-
cence. The repair frequencywas calculated as the percentage
of blue cells expressing GFP for the DR-GFP (gene con-
version), EJ5 (NHEJ) and EJ2 (MMEJ) reporters. For the
HR/NHEJ balance, the ratio of green to red cells in each
condition was calculated as published (52). To facilitate the
comparison between experiments, this ratio was normalized
with a control transfected with a control siRNA. For the
SSR, conditions that skew the balance towards an increase
in NHEJ repair result in a fold increase <1, whereas an im-
balance of the SSR towards HRR results in a fold increase
>1. Data represent a minimum of three sets of duplicated
experiments.
DNA end-resection
SMART (Single Molecule Analysis of Resection Tracks)
was performed as previously described (54). Briefly, U2-OS
cells transfected with either siRNA against PABPN1 or a
control siRNA were cultured in the presence of 10 M bro-
modeoxyuridine (BrdU) for 24 h, irradiated with 10 Gy of
IR, and harvested 1 h later. Cells were embedded in low-
melting agarose, and in-gel DNA extraction followed. To
stretch the DNA fibers, silanized coverslips (Genomic Vi-
sion, Bagneux, France) were dipped into the DNA solution
for 15 min and pulled out at constant speed (250 m/s). Cov-
erslips were baked for 2 h at 60◦C and incubated without
denaturation with an anti-BrdU mouse monoclonal anti-
body. After washing with PBS, coverslips were incubated
with a secondary antibody for 1 h at room temperature.
The coverslips were mounted with ProLong R Gold An-
tifadeReagent (Molecular Probes) and stored at −20◦C.
DNA fibers were observed with a Nikon NI-E microscope
under a PLAN FLUOR DLL 40×/0.75 PHL objective.
The images were recorded and processed using NIS ELE-
MENTS Nikon software. For each experiment, at least 200
DNA fibers were analyzed, and the length of DNA fibers
was measured using Adobe Photoshop CS4 Extended ver-
sion 11.0 (Adobe Systems Incorporated). Statistical signifi-
cance in these experiments was determined with the paired
Student’s t-test using the PRISM software (Graphpad Soft-
ware Inc.).
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Immunoprecipitation mass spectrometry
U2-OS cells were transfected with siLuciferase or
siPABPN1 (as control), treated 72 h later with 50 ng/ml
NCS for 30 min, harvested and kept at –80◦C. Cell pellets
were thawed on ice, resuspended in 1 ml lysis buffer (1%
IGEPAL-CA- 630 (NP-40), 1 mM MgCl2, 1× protease
inhibitors, EDTA-free, 1% Benzonase, 150 mM NaCl 50
mM, Tris–HCl (pH 7.5)) for 30 min at room temperature
and centrifuged at 13 000 × g at 4◦C for 15min. Super-
natants were transferred to new tubes and incubated with
pPABPN1 or total PABPN1 antibodies overnight at 4◦C
while rotating. Protein-A sepharose beads were washed
four times and centrifuged between each time (5000 RPM,
2 min, 4◦C) and incubated with the immune complexes
for 1 h while rotating at 4◦C. The immunoprecipitated
complexes were washed three times with buffer I (0.05%
IGEPAL-CA-630 (NP-40), 150 mM NaCl, 50 mM Tris–
HCl (pH 7.5)) followed by three times with buffer II (150
mM NaCl, 50 mM Tris–HCl (pH 7.5)). The complexes
were trypsin-digested and eluted with 100 l elution buffer
I (2 M urea, 50 mM Tris–HCl -pH 7.5, 1 mM DTT and
0.4 g sequencing grade trypsin) at room temperature for
2 h. The supernatants were transferred to new tubes and
eluted with 100 l elution buffer II (2 M urea, 50 mM
Tris–HCl pH 7.5 and 5 mM iodoacetamide). The proteins
were digested overnight, and the digestion was terminated
by 0.1% trifluoroacetic acid (TFA). The peptides were
desalted, concentrated on C18 stage tips, eluted using 80%
acetonitrile, vacuum-concentrated and diluted in loading
buffer (2% acetonitrile and 0.1% trifluoroacetic acid). The
eluted peptides were loaded onto a 50 cm long EASY-spray
reverse phase column coupled on line to a Q Exactive Plus
mass spectrometer. Peptides were separated using a 240-
min linear gradient of water and acetonitrile. Raw files were
analyzed with MaxQuant (55) software (version 1.5.2.10),
with an - FDR threshold of 0.01 on the peptide and protein
identification. Bioinformatics and statistical analyses were
performed using the Perseus program (56). To identify
the proteins that interact specifically with p-PABPN1,
log2 protein intensities of siLuciferase were compared to
siPABPN1 samples and proteins >2-fold expression in at
least two of three replicates were selected as the interactors.
Similar analysis were done for total PABPN1 interactors.
Protein-protein interaction network for phospho and total
PABPN1 were performed in Cytoscape (3.2.1).
Deposition of mass-spectrometric data
The data are available via ProteomeXchange with identifier
PXD005913.
3′-Seq
The main 3′-Seq experiment (using 20 ng/ml NCS) con-
structed sequencing libraries using the protocol described in
[PMID: 22747694]. The follow-up experiment using 5 or 10
ng/ml NCS applied a slightly modified protocol described
in [PMID: 26671978].
Analysis of 3′-Seq data
Sequenced reads were aligned to the human genome (hg19)
using Bowtie [REF: PMID: 19261174]. Up to two mis-
matches were permitted in the reads’ seed region (the reads’
first 28 nucleotides). To allow the alignment of reads that
span poly(A) CSs, and therefore contain the start of the
untemplated poly-A tail, Bowtie’s -e parameter was in-
creased to tolerate mismatches in all bases after the seed
region. Only uniquely mapped reads were used in subse-
quent analysis (Supplementary Table S1). To map reads to
genes and genomic regions (for example, 3′ UTRs, introns,
coding sequences, and so on), gene coordinates and anno-
tations were extracted from the human Ensembl-Gene ta-
ble of the University of California, Santa Cruz (UCSC)
browser. Uniquely mapped reads that contained untem-
plated stretches of As were used to identify CSs (Supple-
mentary Figure S4). To reduce false calls stemming from
priming of the oligo-dT primer to internal A-rich regions
within transcripts, we required that, to support a CS call,
reads should contain a stretch of at least eight As and at
least five of the first eight As in the stretch should mis-
match the corresponding bases on the transcript reference
sequence. The location of the cleavage was taken as the lo-
cation where the untemplated A stretch started. Since the
location of the CSs often fluctuated around a major site, we
calculated for each gene and sample a ‘poly(A) CS profile’
that recorded the number of reads supporting a cleavage at
each position along the transcript. We considered the lo-
cal maxima of these CS profiles the CS locations, and re-
quired spacing of at least 50 nucleotides between consecu-
tive CSs (in case of lower spacing between CSs, we chose
the stronger, that is, the one supported by a higher num-
ber of reads). Only CSs supported by at least ten reads were
considered in subsequent analyses.Differential usage ofCSs
was identified using chi-square test (and BH-FDR correc-
tion for multiple testing).
RNA-seq
RNA-seq data from PABPN1-depleted and control cells
were used to estimate changes in gene expression that result
from attenuated expression of PABPN1. Expression levels
were estimated by rpkm-normalized counts of the number
of reads that map to each gene followed by quantile nor-
malziation. Fold-change (log2) in expression were subse-
quently calculated per gene between the PABPN1-depleted
and control samples. To avoid inflation of high fold-change
levels for lowly expressed genes, expression levels<1.0 were
set to 1.0. Sequenced reads were aligned to the human
genome (hg19) using tophat. Only uniquley mapped reads
were considered.
RESULTS
PABPN1 is phosphorylated in an ATM-dependent manner on
Ser95 following DSB induction
PABPN1 was identified in our lab as a target of ATM-
dependent phosphorylation in a screen that monitored nu-
clear phosphoproteome dynamics in response to DNA
damage (31). Furthermore, the phosphorylation site was
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identified in that screen on Ser95 of this protein. In order
to validate this phosphorylation, a phospho-specific, poly-
clonal antibody was raised against the presumed phospho-
rylated form of PABPN1. Following 30 min of treatment
with the DSB-inducing chemical, neocarzinostatin (NCS),
we observed in cellular extracts a signal that was markedly
reduced upon PABPN1 depletion using RNAi (Figure 1A).
To verify the specificity of the antibody to pS95 of PABPN1,
we expressed in cells ectopic, GFP-tagged PABPN1 in wild-
type (WT) or in a S95A mutant non-phosphorylatable
version. Indeed, the S95A substitution completely abol-
ished PABPN1 phosphorylation (Figure 1B), substantiat-
ing Ser95 as the phosphorylation site and attesting to the
antibody’s specificity.
To assess the fraction of cellular PABPN1 that is phos-
phorylated in response to DNA damage, we used the
phospho-specific antibody for immunoprecipitation from
extracts of NCS-treated cells and subjected the immune
complexes and supernatant to immunoblotting with anti-
bodies against phosphorylated or total PABPN1. Only a
portion of the cellular content of PABPN1 was found to be
phosphorylated followingNCS treatment (Figure 1C). This
is typical of many DDR players that are borrowed from
other arenas. Notably, we observed PABPN1 phosphory-
lation also in response to two other DSB inducers, ionizing
radiation (IR) and etoposide (Supplementary Figure S1A
and B).
The ATM dependence of PABPN1 phosphorylation,
which had been reflected in the results of the screen that
discovered it as potential DDR player (31), could now be
readily validated using an ATM inhibitor (Figure 2). No-
tably, inhibitors of ATR or DNA-PK did not reduce this
phosphorylation following NCS treatment (Figure 2). In
cells treated with a DNA-PK inhibitor, no reduction in the
damage-induced phosphorylation PABPN1 or KAP-1, a
documented ATM substrate (57), was observed over time.
Notably, it has been recently shown that DNA-PK inhibi-
tion leads not only to DSB persistence due to the hampered
function of NHEJ but also to persistence of ATM activa-
tion due to loss of inhibitory effect of DNA-PK on ATM
activity (58). The PIKKs ATM, DNA-PK and ATR target
mainly S/TQ motifs (59,60). Indeed, Ser95 of PABPN1 is
followed by a glutamine residue, making it a likely ATM
target.
PABPN1 phosphorylation was characterized by rapid ki-
netics, which is typical of many ATM targets, peaking 30–
60 min after DSB induction and largely decaying within
3 hours (Supplementary Figure S2A). Finally, PABPN1
phosphorylation intensified with increasing doses of NCS
or IR (Supplementary Figures S2A, S1A). Collectively,
these results establish Ser95 of PABPN1 as an ATM tar-
get in response to DSB induction and suggest a role for
PABPN1 in the ATM-dependent DSB response.
PABPN1-deficient cells present NCS hypersensitivity and
prolonged cell-cycle arrest in response to DSB induction
Two important hallmarks of cells devoid of ATM are hy-
persensitivity to DSB-inducing agents and defective activa-
tion of the cell-cycle checkpoints by DSBs (61,62). Many
DDR players show a similar effect on cell survival but less
commonly interfere with cell-cycle checkpoint activation
(49,57,63,64). PABPN1 depletion increased the sensitivity
of cells toNCSor IR (Figure 3A, Supplementary Figure S3)
and led to a striking cell cycle arrest at the G2/Mboundary
that persisted 48 hours after damage induction (Figure 3B
and C). Collectively, the results substantiated our assump-
tion that PABPN1 plays a role in the ATM-dependent re-
sponse to DNA damage.
APA is not globally modulated following DSB induction
RBPs may act in the DDR by binding and regulating
the expression of pre-mRNAs that encode DDR play-
ers. It was previously reported that PABPN1 depletion re-
sulted in global enhancement of cleavage and polyadenyla-
tion of proximal cleavage sites (CSs), which caused broad
3′UTR shortening at dozens of transcripts (43). We there-
fore sought to examine whether PABPN1 phosphoryla-
tion by ATM in response to DNA damage could also ex-
ert a global effect on APA. To examine this on a genomic
scale, we first tested whether APA is modulated in response
to DSB induction. We applied 3′-Seq, a deep-sequencing
technique that allows precise mapping of 3′-end cleavage
and polyadenylation sites at a nucleotide resolution (65)
(Supplementary Figure S4). 3′-Seq also quantifies the us-
age of alternative CSs within 3′UTRs based on the num-
ber of reads that map to each of these sites, enabling detec-
tion of APA events induced under different biological con-
ditions. Previous 3′-Seq studies demonstrated that, under
highly proliferative conditions, usage of proximal 3′UTR
CSs is significantly enhanced, resulting in global 3′UTR
shortening (66–68), similar to the global effect observed in
PABPN1-deficient cells (43,44).
We applied 3′-Seq to U2-OS cells that had been treated
with 20 ng/ml NCS and harvested 1, 2 and 4 h after treat-
ment, and to untreated control cells harvested at the 4 h time
point. We detected in this dataset 10131 putative poly(A)
CSs; as expected, they were highly enriched for 3′UTRs
(6411 sites mapped to annotated 3′UTRs of protein-coding
genes) (Figure 4A). A further indication of the precision
of the mapping of poly(A) CSs was the observation that
the distribution of the canonical signal for cleavage and
polyadenylation (AAUAAA) and its main variants, exhib-
ited a very sharp peak at the expected location ∼20 nt up-
stream the cleavage site (CS) (Figure 4B).
Seekingmodulation of APA uponDNAdamage, we next
identified 769 3′UTRs that contained more than one CS,
and statistically tested each of them for alteration in the
relative usage of its CSs in response to NCS. This analysis
compared treated samples from each time point to the un-
treated control sample. The comparison between the NCS-
4 h and control samples identified statistically significant
shifts in CS usage in 263 3′UTRs (FDR<5%). When we
examined whether those shifts showed any preference for
proximal or distal CSs, there was no global 3′UTR short-
ening or lengthening in response to DSB induction: 55%
and 45% of the 263 3′UTRs showed enhanced or reduced
usage of the proximal CS, respectively, which is not signifi-
cantly different from the 50%-50% ratio expected by chance
(Figure 4C). Nor was any global effect observed at the other
time points after NCS treatment. Since the dose of 20 ng/ml
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Figure 1. PABPN1 is phosphorylated on Ser95 in response to DSB-inducing agents. (A) Detection of phosphorylated PABPN1 in cellular extracts using
a phospho-specific antibody raised against the presumed phosphorylation site of PABPN1 on Ser95. PABPN1-depleted or -proficient U2-OS cells were
treated with 20 ng/ml of the radiomimetic chemical, NCS, for 1 hr and cellular extracts were subjected to immunoblotting analysis using the indicated
antibodies. (B) Examination of antibody specificity and validation of Ser95 phosphorylation. U2-OS cells expressing ectopic GFP-PABPN1 in WT or
mutant (S95A) versions were treated with 20 ng/ml of NCS for 30 min and cellular extracts were subjected to immunoblotting analysis with the indicated
antibodies. Note the signal obtained using the phospho-specific antibody with theWT protein, but not the mutants. (C) Only a portion of cellular PABPN1
is phosphorylated in response to DNA damage. Anti-pS95/PABPN1 antibody was used for immunoprecipitation of pPABPN1 from extracts of U2-OS
cells treated with 50 ng/ml NCS for 30 min, or untreated cells. Total cell extract, immune complexes and supernatants were subjected to immunoblotting
analysis with the indicated antibodies. (TCE = total cell extract; SUP = supernatant; IgG- served as a control).
NCS is lethal, we examined whether APAmight be globally
modulated in response to lower doses. We were also inter-
ested in whether APA plays a role in late stages of the DDR.
We therefore repeated the experiment using either 5 or 10
ng/ml of NCS and harvested the cells at 2, 6 and 24 h af-
ter treatment. Untreated control was harvested at 2 h. Here,
too, no global effect was observed (data not shown). Collec-
tively, these results indicate that there is no global enhance-
ment or attenuation of usage of proximal CSs in response
to NCS-induced damage and therefore, PABPN1’s function
in the DDR is not associated with its role in regulation of
global APA.
To further examine whether PABPN1 globally regulated
pre-mRNA transcripts by a mechanism other than APA, in
the context of DNA damage, we applied RNA-Seq to U2-
OS cells depleted of PABPN1. 186 and 421 genes were up-
or down-regulated uponPABPN1depletion.We specifically
sought an effect on the expression of DSB repair genes, and
therefore searched the Gene Ontology (GO) lists for genes
annotated as related to NHEJ and HRR (60 and 98 genes,
respectively). Among those genes, only BRCA1 showed
∼3-fold downregulation at the mRNA level in PABPN1-
depleted cells (Supplementary Table S2). Correlatively, pre-
vious RNA-seq’ analysis performed in Hela cells depleted
of PABPN1, demonstrated that 78 and 227 genes were up-
or down-regulated. Here too, the only affected DSB repair-
related genewasBRCA1, showing∼2-fold down-regulation
in terms of mRNA levels, upon PABPN1 depletion (69).
To examine whether this regulation at the mRNA level had
any impact on BRCA1 protein level, we examined its level
in PABPN1-depleted cells using immunoblotting. Impor-
tantly, BRCA1 protein level was not affected in PABPN1-
depleted cells (Supplementary Figure S5) Altogether, these
results strongly suggest that PABPN1’s role in the DSB re-
sponse is not related to regulation of the expression of DSB
repair genes.
Functional significance of PABPN1 phosphorylation in the
DDR and its recruitment to sites of DNA damage
The above results suggested that, like many other DDR
players, PABPN1 is borrowed temporarily from the RNA
arena to serve the DDR. The next question was, whether
PABPN1 functions in processes that take place at DSB sites.
This could be reflected in abrogation of DSB repair upon
PABPN1 depletion.We first monitored the dynamics of two
hallmarks of unrepaired DSBs in PABPN1-depleted cells
following DSB induction: nuclear foci of phosphorylated
histone H2AX (H2AX) (70) and the central DDR player,
53BP1 (71). PABPN1 depletion led to delayed disappear-
ance dynamics of both DSB markers (Figure 5A–C). Im-
portantly, expression of ectopic, WT PABPN1 rescued this
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Figure 2. PABPN1 is a novel ATM substrate in the DSB response. ATM
dependence of PABPN1 phosphorylation following NCS treatment. U2-
OS cells were treated with 20 ng/ml of NCS, with or without 30 min pre-
treatment with 10Mof the chemical ATM inhibitor, KU-55933. Cellular
extracts were subjected to western blotting analysis with the indicated an-
tibodies. Phosphorylated KAP-1 (57) served as control for DNA damage
induction and response. PAPBN1 phosphorylation following NCS treat-
ment is independent ofATRorDNA-PK.U2-OS cells were treatedwith 20
ng/ml of NCS, with or without pretreatment with the chemical inhibitors
NU7441 (DNA-PK inhibitor-10 M) or AZ20 (ATR inhibitor-0.5 M).
Cellular extracts were subjected to immunoblotting analysis with the indi-
cated antibodies. Phosphorylated KAP-1 served as control for DNA dam-
age induction and response.
phenotype, but the S95A mutant protein failed to fully res-
cue it (Figure 5D), suggesting that the phosphorylation at
Ser95 was functionally important in this regard. Further in-
dication that PABPN1 functions in the DDR context at the
sites of DNA damage could be its relocalization to these
sites. We induced spatially localized DNA damage using a
focused laser beam and monitored the localization of ec-
topic GFP-tagged PABPN1. A distinct fraction of GFP-
PABPN1 was recruited to the stripes of laser-induced dam-
age within a few seconds of DNA damage induction, culmi-
nated within a few minutes (Figure 6A) and remained there
for ∼30 min. Importantly, non-phosphorylatable PABPN1
was similarly recruited to laser stripes, and inactivation of
ATM using the ATM inhibitor did not interfere with this
process (Figure 6B and C), indicating that ATM-dependent
phosphorylation of PABPN1 as well as of other ATM tar-
gets was not required for PABPN1 recruitment. Collec-
tively, the results suggested that PABPN1 is physically and
functionally recruited by the DDR and plays an impor-
tant role in the early phases of the DSB response, and
subsequently-in DSB repair.
PABPN1 is required for the function of DSB repair pathways
The delicate balance between DSB repair pathways is
tightly regulated and is crucial for genome integrity (12).
We used a recently established assay to measure the ratio
between the two main DSB repair pathways, C-NHEJ and
HRR (52) in cells depleted of PABPN1. Briefly, the SeeSaw
reporter (Figure 7A), which harbors a CS of the I-SceI nu-
clease, is integrated in the genome of U2-OS cells. Cleavage
by I-SceI induces repair by C-NHEJ, which is measured by
GFP fluorescence, or by HRR, measured by RFP fluores-
cence. The GFP/RFP ratio is indicative of the balance be-
tween the two repair pathways. PABPN1 depletion had no
significant effect on this ratio (Figure 7B). However, when
the involvement of PABPN1 in each of the pathways was
examined separately using well-documented reporters (Fig-
ure 7C and E) (50,51,72), cells devoid of PABPN1 clearly
manifested faulty repair in both pathways (Figure 7D and
F). Since HRR operates in the late S and G2 phases of
the cell cycle, disruption of normal cell cycle dynamics can
interfere with the NHEJ:HRR balance. Notably, the defi-
ciency inHRRwas evident despite themarkedG2/Marrest
observed in PABPN1-depleted cells following NCS treat-
ment (Figure 3B), reinforcing the role of PABPN1 in the
HRR pathway. The sub-optimal repair through HRR can
be ascribed to a defect in deep 5′ to 3′ DNA end-resection
at DSB ends – a prerequisite for HRR (73). To determine
whether PABPN1 plays a role in this process we utilized the
recently developed SMART (Single Molecule Analysis of
Resection Tracks) assay thatmeasures the length of resected
DNA at the level of single molecules (54). Importantly,
PABPN1 knockdown significantly diminished the length of
resected ends in IR-treated cells (Figure 7G). To appraise
PABPN1’s involvement in HRR, we quantified the nuclear
foci of a major HRRplayer, RAD51, which coats DNA sin-
gle strand stretches following the deep end-resection-a vi-
tal step for the initiation of strand invasion in the homol-
ogous recombination process (10). Notably, the fraction of
cells with RAD51 foci in PABPN1-deficient cells was signif-
icantly lower than in PABPN1-proficient cells (Figure 7H).
Importantly, expression of ectopic, WT PABPN1 rescued
this phenotype, but the S95Amutant protein failed to rescue
it (Figure 7I), suggesting that the phosphorylation at Ser95
was functionally significant in this regard. Altogether, these
results firmly establish a role for PABPN1in the regulation
of the two major DSB repair pathways.
Dynamics of PABPN1’s protein-protein interactions follow-
ing DNA damage induction substantiates its involvement in
the DDR
DNA damage-induced protein–protein interactions are
central to the DDR. DSB-induced PABPN1 interacting
proteins were searched for by immunoprecipitation of total-
PABPN1 or phospho-PABPN1 followed bymass spectrom-
etry. Results are presented in Supplementary Table S3. We
assume that the functional importance of PABPN1 in the
DDR is associated with its phosphorylated portion, which
we found to be small (Figure 1C). We therefore expected
to capture valuable DNA damage-induced interactions of
PABPN1 by using the anti-pPABPN1 antibody for im-
munoprecipitation.
We identified a total of 26 proteins that co-
immunoprecipitated with pPABPN1 after NCS treatment
(Figure 8, Table 1). Of these, 7 are 3′-end pre-mRNA
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Figure 3. PABPN1 plays a role in the DDR. (A) PABPN1-depleted cells exhibit NCS hypersensitivity. Shown are survival curves based on clonogenic
growth of HeLa cells transfected with siRNA against Luciferase (control), or ATM or PABPN1, and treated with increasing doses of the NCS. The data
represent three sets of triplicate experiments. Statistical analysis was based on Student’s t test. The tables present p-values and SEM. Immunoblotting
analysis present the extent of protein depletion in this experiment. (B) U2-OS cells transfected with siRNAs against ATM, or PABPN1 or Luciferase were
treated with 3.5 ng/ml of NCS and cell cycle distribution was analyzed at the indicated time points using flow cytometry. The blots show the degree of
protein depletion in this experiment. (C) Bar diagram of G1/G2 ratios derived from the analysis shown in (B).
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Figure 4. Global APAmodulation is not detected following DSB induction. (A) Distribution of the CSs over different genome categories showed a highly
significant enrichment for annotated protein-coding 3′UTRs. (B) As an additional indication of the precision of CS mapping by 3′-Seq, we searched for
PAS signals (the canonical and its main variants) in ±100 nt with respect to the mapped CS. The PAS signals were significantly enriched at the correct
location ∼20 nt upstream the CSs. (C) For each 3′UTR that showed a shift in CS usage upon NCS treatment, the usage of the proximal CS (relative to
the usage of the other CSs in the same 3′UTR) was calculated. We call this relative usage Proximal Usage Index (PUI). A comparison of the distribution
of PUIs between the NCS treated and control samples yielded no difference, indicating that there was neither global enhancement nor global reduction in
usage of proximal CSs upon NCS treatment.
processing and polyadenylation factors, most of which
were previously shown to interact with PABPN1 as part of
the 3′-end pre-mRNA processing complex in unperturbed
cells. Indeed, these proteins were also immunoprecipitated
with total-PABPN1 in untreated and NCS-treated cells
(Figure 8, blue nodes). It will be interesting to see if any of
these proteins belongs to a functional module that includes
PABPN1 and is recruited by the DDR. Importantly, the
other 19 proteins that interact with pPABPN1 following
induction of DNA damage include two well-established
DDR players -DNA-PKcs (PRKDC) and MDC1, corrob-
orating the functional significance of PABPN1 in the DDR.
An intriguing interactor of pPABPN1 is the BUB3 mitotic
checkpoint protein. BUB3 is a member of the mitotic
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Figure 5. PABPN1 presence and phosphorylation are required for timely dissolution of NCS-induced 53BP1 nuclear foci. (A) U2-OS cells transfected
with siLuc or siPABPN1 were treated with 3.5 ng/ml NCS, and co-immunostaining of PABPN1 and 53BP1 was carried out 8 h later. Note the striking
difference between PABPN1-positive and -negative cells with regard to presence of 53BP1 foci. (C) Average counts of 53BP1 foci at various time points
after treatment with 3.5 ng/ml NCS in PABPN1-proficient and -deficient cells (average of 100 cells). Bars represent SEM. Only cells negatively stained for
PABPN1 were considered PABPN1-deficient. (C) Average counts of H2AX nuclear foci at various time points after irradiation with 1 Gy IR in PABPN1-
proficient and –deficient cells (average of 100 cells). Bars represent SEM. Only cells negatively stained for PABPN1 were considered PABPN1-deficient. (D)
Similar analysis as in (B) of cells in which endogenous PABPN1 was depleted and cells in which it was replaced by ectopic, WT or S95A mutant PABPN1.
The data represent five sets of experiments for 53BP1 and two sets for H2AX. Error bars represent SEM. Statistical analysis was based on Student’s t
test.
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Figure 6. PABPN1 is physically recruited to sites of DNA damage. Live imaging snapshots demonstrate the accumulation of ectopic GFP-PABPN1 in
WT (A) or S95A (B) form in areas of laser-induced DNA damage in U2-OS cells. Note the kinetics of PABPN1 recruitment to DNA damage sites (lower
panel of A). (C) Lack of effect on PABPN1 recruitment of the ATM inhibitor, KU55993 applied at 10 M 30 min prior to irradiation. Recruitment of
GFP-tagged polynucleotide kinase-phosphatase (GFP-PNKP) (63,119) served as control for induction of DNA damage.
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Figure 7. PABPN1 is required for optimal DSB repair. (A, B) Effect of PABPN1 depletion on NHEJ/HRR ratio. Cells were transfected with the indicated
siRNAs and the SSR 2.0 assay was applied (52). The ratio of green to red cells was calculated and normalized for each siRNA against the effect of a
scrambled siRNA (siScr). An NHEJ/HRR ratio different from the baseline value of 1.0 indicates an imbalance between the two DSB repair pathways.
Depletion of the protein CtIP, which is essential for proper end-resection (120) served as a positive control. Bars represent the average and standard
deviation of three independent experiments. (C, D) PABPN1 is necessary for efficient C-NHEJ. The EJ5 reporter (72) is constructed such that I-SceI-
induced DSB can be repaired by NHEJ, recreating an active GFP gene that does or does not contain a functional I-SceI target site. The percentage of
green cells, calculated as described in (51), was normalized against cells transfected with a control siRNA. (E, F) PABPN1 is required for proper HRR. The
DR-GFP reporter (50) is formed by two non-functional copies of the GFP. Gene conversion induced by an I-SceI-mediated DSB restores an active GFP
gene. The efficiency of gene conversion was calculated as described for NHEJ. (G) PABPN1 is required for efficient DNA-end resection at DSB sites. Single
Molecule Analysis of Resection Tracks (SMART) analysis (54) of cells depleted of PABPN1 or the end-resection regulator CtIP. The length of individual
fibers was measured and the median of at least 250 fibers was calculated. (siScr= siScramble). (H) PABPN1 depletion impairs the assembly of RAD51 foci
at DSB in response to DSB induction. U2-OS cells transfected with siRNAs against Luciferase (control) or PABPN1 were treated with 3.5 ng/ml NCS,
and stained at the indicated time points for RAD51. Bars represent percentage of RAD51 positive cells (a minimum of 200 cells were counted). The data
represent three sets of experiments. Error bars represent SEM. Statistical analysis was based on chi-square test. (I) Similar analysis as in (H) of cells in
which endogenous PABPN1 was depleted and cells in which it was replaced by ectopic, WT or S95A mutant PABPN1.
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Figure 8. Protein-protein interactions of phospho-PABPN1 following in-
duction of DNA damage. U2-OS cells were treated with 50 ng/mlNCS for
30 min and cell lysates were used for immunoprecipitation using antibod-
ies against pPABPN1 or total PABPN1. The immune complexes were sub-
jected to mass spectrometry analysis. The specific interactors of pPABPN1
are presented. Red nodes – proteins that precipitated only with phospho-
PABPN1. Blue nodes––proteins that precipitated with both phospho- and
total-PABPN1.
checkpoint complex (MCC, composed also of MAD2 and
BUBR1), which was recently shown to be regulated by
ATM and MDC1 (74). This interesting interaction may
provide insights into the role of PABPN1 in the damage-
induced G2/M cell-cycle checkpoint. Other proteins in this
group are associated with RNA metabolism: most notably
the promiscuous RBP hNRNPC, which is highly prevalent
as a recurrent hit DDR screens (for instance, (28–31,75–
77)), which functions there in its capacity as regulator
of mRNA expression (78,79). Likewise, SNRPF, a core
component of the spliceosome that regulates pre-mRNA
splicing, was recently identified in a DDR screen to be
targeted by ubiquitination following both IR and UV treat-
ment (80,81). Other notable interactors include NUP98
and NUP93––members of the nuclear pore complexes
(NPCs). NPCs play a role in posttranscriptional regulation
by selectively controlling the translocation of nuclear
mRNA into the cytoplasm, where translation subsequently
takes place (82). Interestingly, NUP98 and NUP93 were
previously identified in proteomic screens to be phosphory-
lated, dephosphorylated and ubiquitylated following DNA
damage induction (80,83,84). Another interactor linked to
the RNA field is the RBP LRPPRC, which also turned up
in various screens for new DDR players (80,85,86). The
precise role of LRPPRC is unknown, but studies indicate
that it functions in different aspects of RNA metabolism,
especially in transcriptional regulation of both nuclear and
mitochondrial genes (87–91). Collectively, these results
may point to a suit of RNA metabolism players which,
together with PABPN1, are physically and functionally
recruited by the DDR from their regular context.
DISCUSSION
Numerous cellular physiological pathways are temporarily
integrated into the DDR, contributing to the rapid forma-
tion of this elaborate network upon induction ofDNAdam-
age. The physical proximity of RBPs to chromatin together
with their multiple capacities makes them accessible and in-
teresting candidates for such temporary integration in the
DDR network. The emerging role of RBPs in the DDR is
reflected in the steep rise of the appearance of these pro-
teins as hits in proteomic and functional screens for DDR
players (27–31). Indeed, the awareness to this growing in-
terface between the RNAmetabolism and genome stability
arenas is rapidly growing (32,33,36) and it has become evi-
dent that RBPs can potentially act in the vicinity of DNA
damage sites or remotely by altering gene expression (32–
38). A recent interesting example obtained in yeast is the
involvement of S. cerevisiae RNA decay factors in regu-
lation the process of single-strand DNA coating by repli-
cation protein A, at DSB sites––a critical process in DSB
repair (92). Notably, several established DDR players have
an RNA binding capacity, including 53BP1, KU70, KU80,
ATR and BRCA1 (93–97), though the functional signifi-
cance of this capability in the DDR is still unclear. An im-
portant facet of the RNA-DDR link is the recent discovery
of the production of small, non-coding RNA molecules at
DSB sites, which are required for optimal activation of the
DDR (98–101).
Screens searching for ATM targets identified RBPs as
important modules in the ATM-mediated DDR network
(30,31), but few studies have focused on detailed analysis of
ATM-dependent PTMs of individual RBPs. We were there-
fore intrigued by the identification of PABPN1 as a hit in
our phosphoproteomic screen (31). Our results firmly estab-
lish PABPN1 as a novel target of ATM in response to DSBs
and a new player the delicate regulation ofDSB repair path-
ways. The dynamics of its ATM-mediated phosphorylation
is typical of many ATM targets, and our results attest to the
functional importance of this phosphorylation.
PABPN1-depleted cells exhibited both radiomimetic hy-
persensitivity, which usually indicated faulty DSB repair,
and a pronounced G2/M cell-cycle arrest in response to
DSB induction - two characteristics of cells devoid of ATM
(61,62). A possible link between PABPN1 and cell cycle
control may come from its possible interaction with the
BUB3 mitotic checkpoint protein, suggested by our pro-
teomic results. BUB3 is a member of the mitotic checkpoint
complex (MCC), which is the central activator of the mi-
totic spindle assembly checkpoint (SAC). The SAC controls
metaphase-to-anaphase transition by guaranteeing the fi-
delity of chromosome segregation (102–104). Intriguingly,
ATM and MDC1 were recently shown to control the for-
mation of an intact MCC during SAC activation (74). It
was demonstrated that H2AX is phosphorylated at mitotic
kinetochores by ATM upon SAC induction, and MDC1
interacts with the MCC in a manner dependent on this
phosphorylation. Interestingly, the scaffold DDR protein,
MDC1, appeared among the potential binding partners of
pPABPN1 in our proteomic analysis. Possible functional in-
teraction among pPABPN1, BUB3 and MDC1 may pro-
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Table 1. List (A–Z) of PABPN1 protein–protein interactors (see Figure 8). Hits in previous screens for DDR players are indicated. In red - proteins that co-
precipitated with pPABPN1 after NCS treatment. In blue: proteins that co-precipitated with pPABPN1 after NCS treatment and also with total PABPN1
in untreated and in NCS-treated cells
Gene name Description Gene id
Hits in previous screens for
DDR players (refs.)
APOBEC3B Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3B 9582 (28,80)
ARHGEF2 Rho/Rac Guanine Nucleotide Exchange Factor 2 9181 (80,121)
ATAD3A ATPase Family, AAA Domain Containing 3A 55210
ATP2A2 ATPase Sarcoplasmic/Endoplasmic Reticulum Ca2+
Transporting 2
488 (80,81,122)
BUB3 BUB3, Mitotic Checkpoint Protein 9184 (29,75,80,81)
DNTTIP1 Deoxynucleotidyltransferase Terminal Interacting Protein 1 116092 (80,81)
DSP Desmoplakin 1832 (30,80,81,84)
HNRNPC Heterogeneous Nuclear Ribonucleoprotein C (C1/C2) 3183 (27–31,75–77,80,81,123,124)
LRPPRC Leucine Rich Pentatricopeptide Repeat Containing 10128 (80,86,121)
MDC1 Mediator Of DNA Damage Checkpoint 1 9656
(30,31,77,80,81,83,84,121,125,126)
MPRIP Myosin Phosphatase Rho Interacting Protein 23164 (84)
NUP93 Nucleoporin 93 9688 (80,81,83,84)
NUP98 Nucleoporin 98 4928 (80,84)
PLOD1 Procollagen-Lysine,2-Oxoglutarate 5-Dioxygenase 1 5351
PLOD2 Procollagen-Lysine,2-Oxoglutarate 5-Dioxygenase 2 5352 (29,30)
PRKDC DNA-PK Catalytic Subunit 5591 (30,31,76,77,80,81,83,84,127)
RAB34 RAB34, Member RAS Oncogene Family 83871 (80,81,84,128)
RAI14 Retinoic Acid Induced 14 26064 (27,80,83,84)
SNRPF Small Nuclear Ribonucleoprotein Polypeptide F 6636 (80,81)
PABPC1 Poly(A) Binding Protein Cytoplasmic 1 26986 (28,30,75,80,129,130)
PABPC4 Poly(A) Binding Protein Cytoplasmic 4 8761 (80,128,129)
SKIV2L2 Ski2 Like RNA Helicase 2 23517 (30,80)
ZC3H11A Zinc Finger CCCH-Type Containing 11A 9877 (30,31,80,84,131)
ZC3H14 Zinc Finger CCCH-Type Containing 14 79882 (27,30,31,80,83)
ZC3H3 Zinc Finger CCCH-Type Containing 3 23144 (84)
ZCCHC8 Zinc Finger CCHC-Type Containing 8 55596 (30,81)
vide insights into the prolonged G2/M cell cycle arrest ob-
served in PABPN1-deficient cells following DSB induction.
Our initial interest in PABPN1 as potential DDR player
stemmed from its role in a global process affecting the
expression of many genes––APA (43–45). Our hypothe-
sis was that ATM might regulate APA by phosphorylat-
ing PABPN1. Our first question was, whether APA was in-
deed modulated in response to DNA damage. In two in-
dependent large-scale 3′-RNA-seq’ experiments we found
that APA was not globally modulated in NCS-treated cells.
While our experiments point to some individual pre-mRNA
transcripts that might be regulated by APA in response to
DNA damage, the absence of a global and consistent trend
in regulated transcripts (3′UTR shortening or lengthening)
makes tracking them somewhat arbitrary. Furthermore,
taking into account the global effect of PABPN1 on APA
suppression (i.e. strong 3′UTR shortening in PABPN1-
depleted cells), we would expect that if such regulation ex-
isted in the context of DNA damage, it too would manifest
globally.
The role of PABPN1 in global regulation of pre-mRNA
transcripts reaches beyond the scope of APA, as evidenced
by its longstanding role in poly(A) tail binding of all nascent
pre-mRNAs (40–42,105,106). The poly(A) tail influences
many aspects of mRNA metabolism, including subcellu-
lar localization, mRNA stability and translation efficiency
(107,108). Furthermore, PABPN1 globally regulates the ex-
pression of non-coding RNAs (ncRNAs), including long
non-coding RNAs (lncRNAs) and small nucleolar RNAs
(snoRNAs) (69,105,109,110), the importance of which is
increasingly evident in the DDR (36,37,111). Nevertheless,
RNA-seq analysis in PABPN1-depleted cells performed by
us and others indicate that PABPN1s role in the DDR is
probably not related to pre-mRNA expression regulation.
Yet, we cannot rule out the possibility that PABPN1 glob-
ally regulates mRNA stability and/or ncRNAs by a mech-
anism other than APA in the context of DNA damage.
We were, however, able to show clearly PABPN1’s role in
the regulation of DSB repair, and its physical recruitment
to DSB sites, a typical characteristic of proteins that func-
tion in this capacity. Intriguingly, PABPN1 is important
for optimal function of both NHEJ and HRR. Previously,
we found that the monoubiquitylation of histone H2B at
DSB sites was important for timely function of both repair
pathways (49). The concomitant effect on both processes
could be explained by the role of H2B monoubiquitylation
in a basic process that is critical for DSB repair––relaxation
of the 30 nm chromatin fiber (112). PABPN1’s function in
NHEJmight be associatedwith its physical associationwith
DNA-PKcs, suggested by our proteomic analysis. Notably,
this is not the first time that DNA-PK and PABPN1 are
involved in the same process. PABPN1 is associated with
RNA polymerase II (RNAP II) during transcription and
is thought to take part in the kinetic coupling between 3′-
end pre-mRNA formation and transcription termination
(113,114). Interestingly, it was recently demonstrated that
NHEJ proteins, including DNA-PKcs, form a multipro-
tein complex with RNAP II (115) and the arrest of RNA
polymerase II transcription, which occurs concomitant to
DSB induction, is DNA-PK-dependent (38,116). Notably,
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DNA-PK and PABPN1 both arrive quickly at DSB sites.
Moreover, it has been recently shown that C-NHEJ repairs
transcribed genes and that nascent pre-mRNA are part of
the NHEJ complex and might serve as a template to re-
trieve missing information through error-free end joining
(115). Hence, it is possible that the role of PABPN1 in pre-
mRNA metabolism is utilized to process such RNAs in the
DDR. Interestingly, a recent study demonstrated that tran-
script RNA is also used as template for DSB repair in HRR
pathway (117). As for HRR, the marked cell-cycle arrest
at the G2/M boundary in cells depleted of PABPN1 sub-
stantiates the finding of defective HRR in the absence of
this protein. We found that PABPN1 is required for effi-
cient DNA end-resection at DSB ends, an initial key step
in this pathway. Few other RNA binding factors such as
hnRNPU-like proteins were shown to be required for pro-
ficient DNA-end resection (118). Indeed, another possi-
ble PABPN1 interactor that we identified is the prominent
RBP, hNRNPC, which is recruited to DNA damage sites
as part of the BRCA1/BRCA2/PALB2 complex and is re-
quired for correct pre-mRNA splicing and elevated expres-
sion of several HRR factors, including BRCA2, BRCA1,
and RAD51 (78,79). PABPN1 and hnRNPC are both nu-
clear RBPs containing an RNA recognition motif (RRM),
acting in similar facets of RNAmetabolism. It would be in-
teresting to investigate whether PABPN1 interacts with the
BRCA1/BRCA2/PALB2 complex, andwhether its involve-
ment in theHRRpathway is associatedwith its physical link
to hNRNPc. Furthermore, the identification of PABPN1 as
an ATM target and a crucial player in the cellular response
to DSBs establishes a novel ATM dependent-link between
RNA binding proteins and the DDR.
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